Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
accuracy, adversely, aka, Avenue, average, bearing, borrowing, calculated, Commitment, Connecticut, contractual, create, dba, difficult, discover, discretionary, diversified, Dominari, economy, effort, employee, energy, enhance, environment, evolve, Exploration, explore, Federal, Fieldpoint, final, Finally, fintech, fixed, floor, foster, FPS, global, higher, highly, historical, hundred, implicit, incremental, inflation, invasion, Kyle, lease, line, macroeconomic, membership, month, monthly, Payward, possession, practice, predicted, primary, purpose, recession, remaining, rendered, rent, Reserve, Russia, seller, serve, shifted, strategic, stronger, Supplemental, therewith, Tower, traded, Trump, Ukraine, UM, unrecognized, Variable, variety, volatile, volatility, weighted, wholly, Wool, Yanka, York
Removed:
acting, addition, adjustment, advance, advanced, Alexander, AML, announced, attributed, Austin, Baltimore, beginning, broadly, candidate, care, cell, chemotherapeutic, chemotherapy, compound, constantly, covered, demonstrated, developed, direction, Drs, educational, eligible, exercisable, expect, experienced, focused, foreign, Forest, Frieman, fully, gemcitabine, generation, grow, hope, identify, inhibitory, intended, invented, IPO, lung, MacKerell, Master, Matthew, melanoma, MLA, nasdaq, observed, oncology, overcome, potent, preclinical, priority, product, provisional, renowned, resistance, separate, Sponsored, standard, strong, Stuart, support, targeted, targeting, therapeutic, therapy, tolerated, toxicity, tumor, UMB, viral, Wake, Watson, world
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view